Advocacy Center Decries Drug PA for Hospice Patients

In a recent online alert– reprinted in its entirety below – the Center for Medicare Advocacy(CMA) challenges as “illogical” and “immoral” the Centers for Medicare & Medicaid Services’ (CMS) decision to mandate prior authorization under Part D for drugs prescribed for hospice patients. CMA equates the policies contained in the March 10 guidance, which takes…